Arterial stiffness in hypertensives in relation to expression of angiopoietin-1 and 2 genes in peripheral monocytes

Journal of Human Hypertension

Volumn 24, Issue 5, 2010, Pages 306-311

  Marketou, M E ^a   Kontaraki, J E ^a   Tsakountakis, N A ^b   Zacharis, E A ^a   Kochiadakis, G E ^a   Arfanakis, D A ^a   Chlouverakis, G ^c   Vardas, P E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Kastelli Health Center   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Angiopoietin; Arterial stiffness; Pulse wave velocity

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; MESSENGER RNA;

AGED; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY PULSE; CELL ISOLATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY FLOW; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PULSE WAVE; RADIAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANTIGENS, CD14; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERIES; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 77951131504     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.95     Document Type: Article

References (33)

1. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
2. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
3. Asmar R. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications. Am J Cardiovasc Drugs 2001; 1: 387-397.
4. Felmeden DC, Spencer CG, Chung NA, Belgore FM, Blann AD, Beevers DG et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol 2003; 92: 400-405.
5. Nadar S, Blann AD, Lip GY. Effects of aspirin on intraplatelet vascular endothelial growth factor, angiopoietin- 1, and P-selectin levels in hypertensive patients. Am J Hypertens 2006; 19: 970-977.
6. Nadar SK, Blann A, Beevers DG, Lip GY. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 2005; 258: 336-343.
7. Kiefer FN, Neysari S, Humar R, Li W, Munk VC, Battegay EJ. Hypertension and angiogenesis. Curr Pharm Des 2003; 9: 1733-1744.
8. Felmeden DC, Spencer CG, Belgore FM, Blann AD, Beevers DG, Lip GY. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 2003; 16: 11-20.
9. Fabris L, Cadamuro M, Libbrecht L, Raynaud P, Spirlí C, Fiorotto R et al. Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. Hepatology 2008; 47: 719-728.
10. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. European Network for non-invasive investigation of large arteries Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
11. Zapolska-Donar D, Siennicka A, Chełstowski K, Widecka K, Goracy I, Haasa M et al. Is there an association between angiotensin-converting enzyme gene polymorphism and functional activation of monocytes and macrophage in young patients with essential hypertension? J Hypertens 2006; 24: 1565-1573.
12. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
13. Panutsopulos D, Arvanitis DL, Tsatsanis C, Papalambros E, Sigala F, Spandidos DA. Expression of heregulin in human coronary atherosclerotic lesions. J Vasc Res 2005; 42: 463-474.
14. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-1879.
15. Struijker Boudier HAJ, Le Noble JLML, Messing MWJ, Huijberts MSP, Le Noble FAC, Van Essen H. The microcirculation in hypertension. J Hypertens 1992; 10(Suppl 7): 147-156.
16. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects 470 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046-2050. (Pubitemid 34219760)
17. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-2090.
18. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.
19. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52: 237-268.
20. Dewachter L, Adnot S, Fadel E, Humbert M, Maitre B, Barlier-Mur AM et al. Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1025-1033.
21. Kitayama H, Maeshima Y, Takazawa Y, Yamamoto Y, Wu Y, Ichinose K et al. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am J Hypertens 2006; 19: 718-727.
22. Le Noble FA, Stassen FR, Hacking WJ, Struijker Boudier HA. Angiogenesis and hypertension. J Hypertens 1998; 16: 1563-1572.
23. Struijker Boudier HA, Le Noble JL, Messing MW, Huijberts MS, Le Noble FA, Van Essen H. The microcirculation and hypertension. J Hypertens 1992; 10: S147-S156.
24. Tsigkos S, Koutsilieris M, Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Invest Drugs 2003; 12: 933-941.
25. Kido M, Du L, Sullivan CC, Deutsch R, Jamieson SW, Thistlethwaite PA. Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents. J Thorac Cardiovasc Surg 2005; 129: 268-276.
26. Long DA, Price KL, Ioffe E, Gannon CM, Gnudi L, White KE et al. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int 2008; 74: 300-309.
27. Lee JS, Song SH, Kim JM, Shin IS, Kim KL, Suh YL et al. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res 2008; 78: 572-580.
28. Sie MP, Mattace-Raso FU, Uitterlinden AG, Arp PP, Hofman A, Hoeks AP et al. TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study. J Hum Hypertens 2007; 21: 431-437. (Pubitemid 46813592)
29. Riou S, Mees B, Esposito B, Merval R, Vilar J, Stengel D et al. High pressure promotes monocyte adhesion to the vascular wall. Circ Res 2007; 100: 1226-1233.
30. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20: 593-596.
31. Dorffel Y, Franz S, Pru A, Neumann G, Rohde W, Burmester GR et al. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis? Atherosclerosis 2001; 157: 151-160.
32. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, on behalf of the ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity the Anglo- Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46: 1753-1760.
33. Zahler S, Kowalski C, Brosig A, Kupatt C, Becker BF, Gerlach E. The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J Immunol Methods 1997; 200: 173-179.